The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• The nonclassical MHC Qa-1b presents monomorphic leader peptides and interacts with CD94/NKG2 receptors on immune cells.
• CD94/NKG2 receptors are expressed on natural killer (NK) cells and CD8+ T cells, playing a role in immune surveillance.

Purpose of the Study:

• To investigate the peptide repertoire presented by Qa-1b under impaired antigen-processing conditions.
• To determine the role of Qa-1b-restricted T cells in recognizing and responding to cells with processing deficiencies.

Main Methods:

• Analysis of peptide repertoire presented by Qa-1b in cells with antigen-processing defects.
• Characterization of CD8+ T cell responses to Qa-1b-restricted neoantigens.
• In vivo T cell priming experiments using identified peptide epitopes.

Main Results:

• Impaired antigen processing leads to a diverse repertoire of peptides presented by Qa-1b, acting as immunogenic neoantigens.
• Qa-1b-restricted CD8+ T cells effectively recognize and target a broad range of processing-deficient cells.
• T cell recognition is dependent on T cell receptor and Qa-1b interaction, with successful in vivo priming observed.

Conclusions:

• Qa-1b plays a crucial role in anti-tumor immunity by presenting neoantigens derived from processing-deficient cells.
• This mechanism involves displacing inhibitory leader peptides and presenting novel immunogenic peptides, thereby recruiting cytotoxic CD8+ T cells.
• The findings suggest a conserved role for Qa-1b and its human homologue, HLA-E, in host defense against cellular processing defects.